Rett Syndrome: A Rosetta Stone for Understanding the Molecular Pathogenesis of Autism

International Review of Neurobiology

Volumn 71, Issue , 2005, Pages 131-165

  LaSalle, Janine M ^a   Hogart, Amber ^a   Thatcher, Karen N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; MECP2 PROTEIN, HUMAN; METHYL CPG BINDING PROTEIN 2;

ANIMAL; AUTISM; CELL NUCLEUS; CHROMATIN; GENE EXPRESSION; GENETICS; HAPPY PUPPET SYNDROME; HUMAN; MULTIGENE FAMILY; PATHOLOGY; PHYSIOLOGY; RETT SYNDROME; REVIEW;

ANGELMAN SYNDROME; ANIMALS; AUTISTIC DISORDER; CELL NUCLEUS; CHROMATIN; GENE EXPRESSION; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MULTIGENE FAMILY; RECEPTORS, GABA-A; RETT SYNDROME;

EID: 33645218385     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(05)71006-0     Document Type: Review

References (158)

1. Akbarian S., Chen R.Z., Gribnau J., Rasmussen T.P., Fong H., Jaenisch R., and Jones E.G. Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol. Dis. 8 (2001) 784-791
2. Amir R.E., Fang P., Yu Z., Glaze D.G., Percy A.K., Zoghbi H.Y., Roa B.B., and Van den Veyver I.B. Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome. J. Med. Genet. 42 (2005) e15
3. Amir R.E., Van den Veyver I.B., Schultz R., Malicki D.M., Tran C.Q., Dahle E.J., Philippi A., Timar L., Percy A.K., Motil K.J., Lichtarge O., Smith E.O., Glaze D.G., and Zoghbi H.Y. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann. Neurol. 47 (2000) 670-679
4. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., and Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2. Nat. Genet. 23 (1999) 185-188
5. Arnoldus E.P., Noordermeer I.A., Peters A.C., Raap A.K., and Van der Ploeg M. Interphase cytogenetics reveals somatic pairing of centromeres in normal human brain tissue, but no chromosome loss. Cytogenet. Cell. Genet. 56 (1991) 214-216
6. Arnoldus E.P.J., Peters A.C.B., Bots G.T.A.M., Raap A.K., and van der Ploeg M. Somatic pairing of chromosome 1 centromeres in interphase nuclei of human cerebellum. Hum. Genet. 83 (1989) 231-234
7. Balmer D., Arredondo J., Samaco R.C., and LaSalle J.M. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum. Genet. 110 (2002) 545-552
8. Balmer D., Goldstine J., Rao Y.M., and LaSalle J.M. Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J. Mol. Med. 81 (2003) 61-68
9. Barnard E.A., Skolnick P., Olsen R.W., Mohler H., Sieghart W., Biggio G., Braestrup C., Bateson A.N., and Langer S.Z. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: Classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50 (1998) 291-313
10. Beyer K.S., Blasi F., Bacchelli E., Klauck S.M., Maestrini E., Poustka A., International Molecular Genetic Study of Autism, and C. Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum. Genet. 111 (2002) 305-309
11. Bienvenu T., Carrie A., de Roux N., Vinet M.C., Jonveaux P., Couvert P., Villard L., Arzimanoglou A., Beldjord C., Fontes M., Tardieu M., and Chelly J. MECP2 mutations account for most cases of typical forms of rett syndrome. Hum. Mol. Genet. 9 (2000) 1377-1384
12. Bittel D.C., Kibiryeva N., Talebizadeh Z., and Butler M.G. Microarray analysis of gene/transcript expression in Prader-Willi syndrome: Deletion versus UPD. J. Med. Genet. 40 (2003) 568-574
13. Bittel D.C., Kibiryeva N., Talebizadeh Z., Driscoll D.J., and Butler M.G. Microarray analysis of gene/transcript expression in Angelman syndrome: Deletion versus UPD. Genomics 85 (2005) 85-91
14. Blaxill M.F. What's going on? The question of time trends in autism. Public Health Rep. 119 (2004) 536-551
15. Borden J., and Manuelidis L. Movement of the X chromosome in epilepsy. Science 242 (1988) 1687-1691
16. Bowen N.J., Palmer M.B., and Wade P.A. DNA damage repair and transcription chromosomal regulation by MeCP2: Structural and enzymatic considerations. Cell. Mol. Life Sci. 61 (2004) 2163-2167
17. Braunschweig D., Simcox T., Samaco R.C., and LaSalle J.M. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain. Hum. Mol. Genet. 13 (2004) 1275-1286
18. Brown K.E., Amoils S., Horn J.M., Buckle V.J., Higgs D.R., Merkenschlager M., and Fisher A.G. Expression of alpha- and beta-globin genes occurs within different nuclear domains in haemopoietic cells. Nat. Cell. Biol. 3 (2001) 602-606
19. Brown K.E., Baxter J., Graf D., Merkenschlager M., and Fisher A.G. Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. Mol. Cell 3 (1999) 207-217
20. Brown K.E., Guest S.S., Smale S.T., Hahm K., Merkenschlager M., and Fisher A.G. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91 (1997) 845-854
21. Buiting K., Barnicoat A., Lich C., Pembrey M., Malcolm S., and Horsthemke B. Disruption of the bipartite imprinting center in a family with Angelman syndrome. Am. J. Hum. Genet. 68 (2001) 1290-1294
22. Buiting K., Gross S., Lich C., Gillessen-Kaesbach G., el-Maarri O., and Horsthemke B. Epimutations in Prader-Willi and Angelman syndromes: A molecular study of 136 patients with an imprinting defect. Am. J. Hum. Genet. 72 (2003) 571-577
23. Buiting K., Saitoh S., Gross S., Dittrich B., Schwartz S., Nicholls R.D., and Horsthemke B. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat. Genet. 9 (1995) 395-400
24. Buschdorf J.P., and Stratling W.H. A WW domain binding region in methyl-CpG-binding protein MeCP2: Impact on Rett syndrome. J. Mol. Med. 82 (2004) 135-143
25. Buxbaum J.D., Silverman J.M., Smith C.J., Greenberg D.A., Kilifarski M., Reichert J., Cook E.H., Fang Y., Song C.Y., and Vitale R. Association between a GABRB3 polymorphism and autism. Mol. Psychiatry 7 (2002) 311-316
26. Byrd K., and Corces V.G. Visualization of chromatin domains created by the gypsy insulator of Drosophila. J. Cell. Biol. 162 (2003) 565-574
27. Casanova M.F., Buxhoeveden D., Switala A., and Roy E. Rett syndrome as a minicolumnopathy. Clin. Neuropathol. 22 (2003) 163-168
28. Casanova M.F., Buxhoeveden D.P., Switala A.E., and Roy E. Minicolumnar pathology in autism. Neurology 58 (2002) 428-432
29. Cassel S., Revel M.O., Kelche C., and Zwiller J. Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study. Neurobiol. Dis. 15 (2004) 206-211
30. Chambeyron S., and Bickmore W.A. Chromatin decondensation and nuclear reorganization of the HoxB locus upon induction of transcription. Genes. Dev. 18 (2004) 1119-1130
31. Chen R.Z., Akbarian S., Tudor M., and Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27 (2001) 327-331
32. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., Jaenisch R., and Greenberg M.E. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302 (2003) 885-889
33. Cohen D.R., Matarazzo V., Palmer A.M., Tu Y., Jeon O.H., Pevsner J., and Ronnett G.V. Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol. Cell. Neurosci. 22 (2003) 417-429
34. Colantuoni C., Jeon O.H., Hyder K., Chenchik A., Khimani A.H., Narayanan V., Hoffman E.P., Kaufmann W.E., Naidu S., and Pevsner J. Gene expression profiling in postmortem rett syndrome brain: Differential gene expression and patient classification. Neurobiol. Dis. 8 (2001) 847-865
35. Collins A.L., Levenson J.M., Vilaythong A.P., Richman R., Armstrong D.L., Noebels J.L., David Sweatt J., and Zoghbi H.Y. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13 (2004) 2679-2689
36. Cook Jr. E.H., Courchesne R.Y., Cox N.J., Lord C., Gonen D., Guter S.J., Lincoln A., Nix K., Haas R., Leventhal B.L., and Courchesne E. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am. J. Hum. Genet. 62 (1998) 1077-1083
37. Cook Jr. E.H., Lindgren V., Leventhal B.L., Courchesne R., Lincoln A., Shulman C., Lord C., and Courchesne E. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 60 (1997) 928-934
38. Coverdale L.E., Martyniuk C.J., Trudeau V.L., and Martin C.C. Differential expression of the methyl-cytosine binding protein 2 gene in embryonic and adult brain of zebrafish. Brain Res. Dev. Brain Res. 153 (2004) 281-287
39. Coy J.F., Sedlacek Z., Bachner D., Delius H., and Poustka A. A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3′-untranslated region of the methyl- CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum. Mol. Genet. 8 (1999) 1253-1262
40. Cremer T., Kurz A., Zirbel R., Dietzel S., Rinke B., Schrock E., Speicher M.R., Mathieu U., Jauch A., Emmerich P., et al. Role of chromosome territories in the functional of the cell nucleus. Cold Spring Harb. Symp. Quant. Biol. 58 (1993) 777-792
41. Culiat C.T., Stubbs L.J., Montgomery C.S., Russell L.B., and Rinchik E.M. Phenotypic consequences of deletion of the gamma 3, alpha 5, or beta 3 subunit of the type A gamma-aminobutyric acid receptor in mice. Proc. Natl. Acad. Sci. USA 91 (1994) 2815-2818
42. D'Esposito M., Quaderi N.A., Ciccodicola A., Bruni P., Esposito T., D'Urso M., and Brown S.D. Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm. Genome 7 (1996) 533-535
43. de Laat W., and Grosveld F. Spatial organization of gene expression: The active chromatin hub. Chromosome Res. 11 (2003) 447-459
44. DeLorey T.M., Handforth A., Anagnostaras S.G., Homanics G.E., Minassian B.A., Asatourian A., Fanselow M.S., Delgado-Escueta A., Ellison G.D., and Olsen R.W. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J. Neurosci. 18 (1998) 8505-8514
45. DeLorey T.M., and Olsen R.W. GABA and epileptogenesis: Comparing gabrb3 gene-deficient mice with Angelman syndrome in man. Epilepsy. Res. 36 (1999) 123-132
46. Dittrich B., Buiting K., Korn B., Rickard S., Buxton J., Saitoh S., Nicholls R.D., Poustka A., Winterpacht A., Zabel B., and Horsthemke B. Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nature Genetics 14 (1996) 163-170
47. Evans J.C., Archer H.L., Whatley S.D., Kerr A., Clarke A., and Butler R. Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls. Eur. J. Hum. Genet. 13 (2005) 124-126
48. Francastel C., Walters M.C., Groudine M., and Martin D.I. A functional enhancer suppresses silencing of a transgene and prevents its localization close to centrometric heterochromatin. Cell 99 (1999) 259-269
49. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., and Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278 (2003) 4035-4040
50. Gauthier J., Bonnel A., St-Onge J., Karemera L., Laurent S., Mottron L., Fombonne E., Joober R., and Rouleau G.A. NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 132 (2005) 74-75
51. Georgel P.T., Horowitz-Scherer R.A., Adkins N., Woodcock C.L., Wade P.A., and Hansen J.C. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278 (2003) 32181-32188
52. Gerard M., Hernandez L., Wevrick R., and Stewart C.L. Disruption of the mouse necdin gene results in early post-natal lethality. Nat. Genet. 23 (1999) 199-202
53. Girard M., Couvert P., Carrie A., Tardieu M., Chelly J., Beldjord C., and Bienvenu T. Parental origin of de novo MECP2 mutations in Rett syndrome. Eur. J. Hum. Genet. 9 (2001) 231-236
54. Glenn C.C., Porter K.A., Jong M.T., Nicholls R.D., and Driscoll D.J. Functional imprinting and epigenetic modification of the human SNRPN gene. Hum. Mol. Genet. 2 (1993) 2001-2005
55. Grande M.A., van der Kraan I., de Jong L., and van Driel R. Nuclear distribution of transcription factors in relation to sites of transcription and RNA polymerase II. J. Cell Sci. 110 Pt. 15 (1997) 1781-1791
56. Guy J., Hendrich B., Holmes M., Martin J.E., and Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27 (2001) 322-326
57. Harikrishnan K.N., Chow M.Z., Baker E.K., Pal S., Bassal S., Brasacchio D., Wang L., Craig J.M., Jones P.L., Sif S., and El-Osta A. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat. Genet. 37 (2005) 254-264
58. Hatakeyama C., Anderson C.L., Beever C.L., Penaherrera M.S., Brown C.J., and Robinson W.P. The dynamics of X-inactivation skewing as women age. Clin. Genet. 66 (2004) 327-332
59. Hendrich B., Abbott C., McQueen H., Chambers D., Cross S., and Bird A. Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. Mamm. Genome. 10 (1999) 906-912
60. Herzing L.B.K., Cook E.H., and Ledbetter D.H. Allele-specific expression analysis by RNA-FISH demonstrates preferential maternal expression of UBE3A and imprint maintenance within 15q11-q13 duplications. Hum. Mol. Genet. 11 (2002) 1707-1718
61. Holowacz T., and De Boni U. Arrangement of kinetochore proteins and satellite DNA in neuronal interphase nuclei: Changes induced by gamma-aminobutyric acid (GABA). Exp. Cell Res. 197 (1991) 36-42
62. Homanics G.E., DeLorey T.M., Firestone L.L., Quinlan J.J., Handforth A., Harrison N.L., Krasowski M.D., Rick C.E., Korpi E.R., Makela R., Brilliant M.H., Hagiwara N., Ferguson C., Snyder K., and Olsen R.W. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. Natl. Acad. Sci. USA 94 (1997) 4143-4148
63. Horike S., Cai S., Miyano M., Cheng J.F., and Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 37 (2005) 31-40
64. Iborra F.J., Pombo A., Jackson D.A., and Cook P.R. Active RNA polymerases are localized within discrete transcription "factories" in human nuclei. J. Cell Sci. 109 Pt. 6 (1996) 1427-1436
65. Jackson D., Hassan A., Errington R., and Cook P. Visualization of focal sites of transcription within human nuclei. EMBO J. 12 (1993) 1059-1065
66. Jackson D.A., Iborra F.J., Manders E.M., and Cook P.R. Numbers and organization of RNA polymerases, nascent transcripts, and transcription units in HeLa nuclei. Mol. Biol. Cell 9 (1998) 1523-1536
67. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., and Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34 (2003) 27-29
68. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
69. Jiang Y.H., Armstrong D., Albrecht U., Atkins C.M., Noebels J.L., Eichele G., Sweatt J.D., and Beaudet A.L. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 21 (1998) 799-811
70. Jiang Y.H., and Beaudet A.L. Human disorders of ubiquitination and proteasomal degradation. Curr. Opin. Pediatr. 16 (2004) 419-426
71. Jiang Y.H., Sahoo T., Michaelis R.C., Bercovich D., Bressler J., Kashork C.D., Liu Q., Shaffer L.G., Schroer R.J., Stockton D.W., Spielman R.S., Stevenson R.E., and Beaudet A.L. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am. J. Med. Genet. 131 (2004) 1-10
72. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., and Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19 (1998) 187-191
73. Jones P.L., Wade P.A., and Wolffe A.P. Purification of the MeCP2/histone deacetylase complex from Xenopus laevis. Methods Mol. Biol. 181 (2001) 297-307
74. Jorgensen H.F., and Bird A. MeCP2 and other methyl-CpG binding proteins. Ment. Retard. Dev. Disabil. Res. Rev. 8 (2002) 87-93
75. Jugloff D.G., Jung B.P., Purushotham D., Logan R., and Eubanks J.H. Increased dendritic complexity and axonal length in cultured mouse cortical neurons overexpressing methyl-CpG-binding protein MeCP2. Neurobiol. Dis. 19 (2005) 18-27
76. Kim S.J., Herzing L.B., Veenstra-Vander Weele J., Lord C., Courchesne R., Leventhal B.L., Ledbetter D.H., Courchesne E., and Cook Jr. E.H. Mutation screening and transmission disequilibrium study of ATP10C in autism. Am. J. Med. Genet. 114 (2002) 137-143
77. Kimura H., and Shiota K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J. Biol. Chem. 278 (2003) 4806-4812
78. Kishino T., Lalande M., and Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15 (1997) 70-73
79. Kosak S.T., and Groudine M. Gene order and dynamic domains. Science 306 (2004) 644-647
80. Kriaucionis S., and Bird A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic. Acids Res. 32 (2004) 1818-1823
81. Lalande M. Parental imprinting and human disease. Ann. Rev. Genet. 30 (1996) 173-195
82. Lam C., Yeung W., Ko C., Poon P., Tong S., Chan K., Lo I., Chan L., Hui J., Wong V., Pang C., Lo Y., and Fok T. Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J. Med. Genet. 37 (2000) E41
83. LaSalle J., Goldstine J., Balmer D., and Greco C. Quantitative localization of heterologous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum. Mol. Genet. 10 (2001) 1729-1740
84. LaSalle J., and Lalande M. Homologous association of oppositely imprinted chromosomal domains. Science 272 (1996) 725-728
85. Laurie D.J., Seeburg P.H., and Wisden W. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J. Neurosci. 12 (1992) 1063-1076
86. Lawler C.P., Croen L.A., Grether J.K., and Van de Water J. Identifying environmental contributions to autism: Provocative clues and false leads. Ment. Retard. Dev. Disabil. Res. Rev. 10 (2004) 292-302
87. Lee S., Walker C.L., Karten B., Kuny S.L., Tennese A.A., O'Neill M.A., and Wevrick R. Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. Hum. Mol. Genet. 14 (2005) 627-637
88. Leitch A.R. Higher levels of organization in the interphase nucleus of cycling and differentiated cells. Microbiol. Mol. Biol. Rev. 64 (2000) 138-152
89. Lewis J.D., Meehan R.R., Henzel W.J., Maurer-Fogy I., Jeppesen P., Klein F., and Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69 (1992) 905-914
90. Li E., Beard C., and Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 366 (1993) 362-365
91. Luikenhuis S., Giacometti E., Beard C.F., and Jaenisch R. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl. Acad. Sci. USA 101 (2004) 6033-6038
92. Makedonski K., Abuhatzira L., Kaufman Y., Razin A., and Shemer R. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum. Mol. Genet. 14 (2005) 1049-1058
93. Manuelidis L. A view of interphase chromosomes. Science 250 (1990) 1533-1540
94. Manuelidis L., and Borden J. Reproducible compartmentalization of individual chromosome domains in human CNS cells revealed by in situ hybridization and three-dimensional reconstruction. Chromosoma 96 (1988) 397-410
95. Martin E.R., Menold M.M., Wolpert C.M., Bass M.P., Donnelly S.L., Ravan S.A., Zimmerman A., Gilbert J.R., Vance J.M., Maddox L.O., Wright H.H., Abramson R.K., DeLong G.R., Cuccaro M.L., and Pericak-Vance M.A. Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder. Am. J. Med. Genet. 96 (2000) 43-48
96. Martinowich K., Hattori D., Wu H., Fouse S., He F., Hu Y., Fan G., and Sun Y.E. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302 (2003) 890-893
97. Martou G., and De Boni U. Nuclear topology of murine, cerebellar Purkinje neurons: Changes as a function of development. Exp. Cell Res. 256 (2000) 131-139
98. McCauley J.L., Olson L.M., Delahanty R., Amin T., Nurmi E.L., Organ E.L., Jacobs M.M., Folstein S.E., Haines J.L., and Sutcliffe J.S. A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism. Am. J. Med. Genet. 131 (2004) 51-59
99. McGrath J., and Solter D. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37 (1984) 179-183
100. McLean P.J., Farb D.H., and Russek S.J. Mapping of the alpha 4 subunit gene (GABRA4) to human chromosome 4 defines an alpha 2-alpha 4-beta 1-gamma 1 gene cluster: Further evidence that modern GABAA receptor gene clusters are derived from an ancestral cluster. Genomics 26 (1995) 580-586
101. Meguro M., Mitsuya K., Sui H., Shigenami K., Kugoh H., Nakao M., and Oshimura M. Evidence for uniparental, paternal expression of the human GABAA receptor subunit genes, using microcell-mediated chromosome transfer. Hum. Mol. Genet. 6 (1997) 2127-2133
102. Miura K., Kishino T., Li E., Webber H., Dikkes P., Holmes G.L., and Wagstaff J. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol. Dis. 9 (2002) 149-159
103. Mnatzakanian G.N., Lohi H., Munteanu I., Alfred S.E., Yamada T., MacLeod P.J., Jones J.R., Scherer S.W., Schanen N.C., Friez M.J., Vincent J.B., and Minassian B.A. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet. 36 (2004) 339-341
104. Moncla A., Malzac P., Voelckel M.A., Auquier P., Girardot L., Mattei M.G., Philip N., Mattei J.F., Lalande M., and Livet M.O. Phenotype-genotype correlation in 20 deletion and 20 non-deletion Angelman syndrome patients. Eur. J. Hum. Genet. 7 (1999) 131-139
105. Moretti P., Bouwknecht J.A., Teague R., Paylor R., and Zoghbi H.Y. Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet. 14 (2005) 205-220
106. Muhle R., Trentacoste S.V., and Rapin I. The genetics of autism. Pediatrics 113 (2004) e472-e486
107. Mullaney B.C., Johnston M.V., and Blue M.E. Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 123 (2004) 939-949
108. Murphy S.K., and Jirtle R.L. Imprinting evolution and the price of silence. Bioessays 25 (2003) 577-588
109. Murrell A., Heeson S., and Reik W. Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat. Genet. 36 (2004) 889-893
110. Nan X., Campoy F.J., and Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88 (1997) 471-481
111. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., and Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393 (1998) 386-389
112. Nan X., Tate P., Li E., and Bird A. DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell. Biol. 16 (1996) 414-421
113. Nicholls R.D., Gottlieb W., Russell L.B., Davda M., Horsthemke B., and Rinchik E.M. Evaluation of potential models for imprinted and nonimprinted components of human chromosome 15q11-q13 syndromes by fine-structure homology mapping in the mouse. Proc. Natl. Acad. Sci. USA 90 (1993) 2050-2054
114. Nicholls R.D., and Knepper J.L. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2 (2001) 153-175
115. Nurmi E.L., Amin T., Olson L.M., Jacobs M.M., McCauley J.L., Lam A.Y., Organ E.L., Folstein S.E., Haines J.L., and Sutcliffe J.S. Dense linkage disequilibrium mapping in the 15q11-q13 maternal expression domain yields evidence for association in autism. Mol. Psychiatry 8 (2003) 624-634 570
116. Nurmi E.L., Bradford Y., Chen Y.-H., Hall J., Arnone B., Gardiner M.B., Hutcheson H.B., Gilbert J.R., Pericak-Vance M.A., Copeland-Yates S.A., Michaelis R.C., Wassink T.H., Santangelo S.L., Sheffield V.C., Piven J., Folstein S.E., Haines J.L., and Sutcliffe J.S. Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families. Genomics 77 (2001) 105-113
117. Osborne A.R., Zhang H., Fejer G., Palubin K.M., Niesen M.I., and Blanck G. Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: An Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter. J. Biol. Chem. 279 (2004) 28911-28919
118. Patrinos G.P., de Krom M., de Boer E., Langeveld A., Imam A.M., Strouboulis J., de Laat W., and Grosveld F.G. Multiple interactions between regulatory regions are required to stabilize an active chromatin hub. Genes. Dev. 18 (2004) 1495-1509
119. Peters S.U., Beaudet A.L., Madduri N., and Bacino C.A. Autism in Angelman syndrome: Implications for autism research. Clin. Genet. 66 (2004) 530-536
120. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., and Sperk G. GABA(A) receptors: Immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101 (2000) 815-850
121. Polleux F., and Lauder J.M. Toward a developmental neurobiology of autism. Ment. Retard. Dev. Disabil. Res. Rev. 10 (2004) 303-317
122. Ravn K., Nielson J., and Schwartz M. Mutations found within exon 1 of MECP2 in Danish patients with Rett syndrome. Clin. Genet. 67 (2005) 532-533
123. Reichwald K., Thiesen J., Wiehe T., Weitzel J., Poustka W.A., Rosenthal A., Platzer M., Stratling W.H., and Kioschis P. Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. Mamm. Genome. 11 (2000) 182-190
124. Reik W., and Walter J. Genomic imprinting: Parental influence on the genome. Nat. Rev. Genet. 2 (2001) 21-32
125. Ren J., Lee S., Pagliardini S., Gerard M., Stewart C.L., Greer J.J., and Wevrick R. Absence of Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. J. Neurosci. 23 (2003) 1569-1573
126. Renieri A., Pescucci C., Longo I., Ariani F., Meloni I., Zappella M., Russo L., Giordano T., Neri G., and Gurrieri F. Rett patients with both MECP2 mutations and 15q11-13 rearrangements. Am. J. Hum. Genet. 73 (2003) 6
127. Rougeulle C., Glatt H., and Lalande M. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain [letter] [In Process Citation]. Nat. Genet. 17 (1997) 14-15
128. Runte M., Huttenhofer A., Gross S., Kiefmann M., Horsthemke B., and Buiting K. The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum. Mol. Genet. 10 (2001) 2687-2700
129. Samaco R.C., Hogart A., and LaSalle J.M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14 (2005) 483-492
130. Samaco R.C., Nagarajan R.P., Braunschweig D., and LaSalle J.M. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum. Mol. Genet. 13 (2004) 629-639
131. Schanen C. Rethinking the fate of males with mutations in the gene that causes Rett syndrome. Brain Dev. 23 Suppl. 1 (2001) S144-S146
132. Schroer R.J., Phelan M.C., Michaelis R.C., Crawford E.C., Skinner S.A., Cuccaro M., Simensen R.J., Bishop J., Skinner C., Fender D., and Stevenson R.E. Autism and maternally derived aberrations of chromosome 15q. Am. J. Med. Genet. 76 (1998) 327-336
133. Services C.D.o.D. "Autism Spectrum Disorders, Changes in the California Caseload, An Update: 1999 to 2002." (2003), California Health and Human Services, Sacramento California Health and Human Services.
134. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., and Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35 (2002) 243-254
135. Shahbazian M.D., Antalffy B., Armstrong D.L., and Zoghbi H.Y. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11 (2002) 115-124
136. Shao Y., Cuccaro M.L., Hauser E.R., Raiford K.L., Menold M.M., Wolpert C.M., Ravan S.A., Elston L., Decena K., Donnelly S.L., Abramson R.K., Wright H.H., DeLong G.R., Gilbert J.R., and Pericak-Vance M.A. Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes. Am. J. Hum. Genet. 72 (2003) 539-548
137. Soejima H., and Wagstaff J. Imprinting centers, chromatin structure, and disease. J. Cell. Biochem. 95 (2005) 226-233
138. Song J., Koller D.L., Foroud T., Carr K., Zhao J., Rice J., Nurnberger Jr. J.I., Begleiter H., Porjesz B., Smith T.L., Schuckit M.A., and Edenberg H.J. Association of GABA(A) receptors and alcohol dependence and the effects of genetic imprinting. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 117 (2003) 39-45
139. Subramaniam B., Naidu S., and Reiss A.L. Neuroanatomy in Rett syndrome: Cerebral cortex and posterior fossa. Neurology 48 (1997) 399-407
140. Sutcliffe J.S., Nakao M., Christian S., Orstavik K.H., Tommerup N., Ledbetter D.H., and Beaudet A.L. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat. Genet. 8 (1994) 52-58
141. Thatcher K., Peddada S., Yasui D., and LaSalle J.M. Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples. Hum. Mol. Genet. (2005) in revision
142. Tolhuis B., Palstra R.J., Splinter E., Grosveld F., and de Laat W. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol. Cell 10 (2002) 1453-1465
143. Tudor M., Akbarian S., Chen R.Z., and Jaenisch R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl. Acad. Sci. USA 99 (2002) 15536-15541
144. Verona R.I., Mann M.R., and Bartolomei M.S. Genomic imprinting: Intricacies of epigenetic regulation in clusters. Annu. Rev. Cell Dev. Biol. 19 (2003) 237-259
145. Vincent J.B., Kolozsvari D., Roberts W.S., Bolton P.F., Gurling H.M., and Scherer S.W. Mutation screening of X-chromosomal neuroligin genes: No mutations in 196 autism probands. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 129 (2004) 82-84
146. Volkmar F.R., and Pauls D. Autism. Lancet 362 (2003) 1133-1141
147. Vourc'h P., Bienvenu T., Beldjord C., Chelly J., Barthelemy C., Muh J.P., and Andres C. No mutations in the coding region of the Rett syndrome gene MECP2 in 59 autistic patients. European J. Hum. Genet. 9 (2001) 556-558
148. Vu T., and Hoffman A. Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nature Genet. 17 (1997) 12-13
149. Wang Y., Fischle W., Cheung W., Jacobs S., Khorasanizadeh S., and Allis C.D. Beyond the double helix: Writing and reading the histone code. Novartis Found Symp. 259 (2004) 3-17 discussion 17-21, 163-169.
150. Wassink T.H., and Piven J. The molecular genetics of autism. Curr. Psychiatry Rep. 2 (2000) 170-175
151. Watson P., Black G., Ramsden S., Barrow M., Super M., Kerr B., and Clayton-Smith J. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J. Med. Genet. 38 (2001) 224-228
152. Weintraub H., and Groudine M. Chromosomal subunits in active genes have an altered conformation. Science 193 (1976) 848-856
153. Weitzel J.M., Buhrmester H., and Stratling W.H. Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG- binding protein MeCP2. Mol. Cell. Biol. 17 (1997) 5656-5666
154. Yamasaki K., Joh K., Ohta T., Masuzaki H., Ishimaru T., Mukai T., Niikawa N., Ogawa M., Wagstaff J., and Kishino T. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum. Mol. Genet. 12 (2003) 837-847
155. Young J.I., and Zoghbi H.Y. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome. Am. J. Hum. Genet. 74 (2004) 511-520
156. Zaidi S.K., Sullivan A.J., van Wijnen A.J., Stein J.L., Stein G.S., and Lian J.B. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc. Natl. Acad. Sci. USA 99 (2002) 8048-8053
157. Zoghbi H.Y. Postnatal neurodevelopmental disorders: Meeting at the synapse?. Science 302 (2003) 826-830
158. Zoghbi H.Y., Percy A.K., Schultz R.J., and Fill C. Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev. 12 (1990) 131-135